Jun 132025 NeuroEM Therapeutics Closes Initial Rounds in $5 Million Equity Raise to Commercialize Drug-free Alzheimer’s Treatment NeuroEM ...

Sound bite for Twitter is: Health Case Consumer stock. Results of stock price testing is that the stock price is probably cheap but could be just ...

Vera Therapeutics: Huge Catalyst Upcoming For Kidney Disease Drug

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 300 points on Monday. Following the market opening Monday, the Dow ...

Multiple patent families and clinical programs empower Inhibikase to combat neuro-degenerative diseases – and serve a vast marketIt’s tragic: Parkinson’s ...

NeuBase is accelerating the genetic revolution with a new class of broad-based but highly targeted medicines Based in Pittsburgh, Pennsylvania, NeuBase ...